Form 4: BDX Executive Michael Feld's Tax-Related Stock Transaction

Becton, Dickinson and Company's EVP & President, Life Sciences, Michael Feld, reported a disposition of 773 common shares for tax withholding purposes.

Summary

• Michael Feld, EVP & President, Life Sciences at Becton, Dickinson and Company (BDX), reported a transaction on August 20, 2025.
• The transaction involved the disposition of 773 shares of BDX Common Stock.
• These shares were withheld for the payment of withholding taxes related to the vesting of previously reported restricted stock unit awards.
• Following this transaction, Michael Feld directly beneficially owns 8,417 shares of BDX Common Stock.

Sentiment

Score: 5

Explanation: The filing details a routine, non-discretionary disposition of shares for tax withholding purposes related to the vesting of restricted stock units. This is a standard event in executive compensation and does not indicate any positive or negative operational or financial developments for the company.

Positives

• Vesting of restricted stock unit awards indicates the achievement of performance or tenure conditions, aligning executive interests with shareholder value.

Negatives

• No direct negatives from this specific transaction, as it is a routine tax-related event.

Risks

• NA

Future Outlook

This filing is a routine disclosure of an executive's stock transaction and does not contain forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This transaction is a standard practice for executives receiving equity compensation, where shares are withheld to cover tax obligations upon the vesting of restricted stock units. This is a common occurrence across various industries, including life sciences, and does not reflect specific industry trends or competitive dynamics.

Comparison to Industry Standards

• The practice of withholding shares for tax purposes upon the vesting of restricted stock units is a widely accepted and standard method of managing executive equity compensation across publicly traded companies.
• This transaction aligns with typical corporate governance and compensation practices observed in the healthcare and life sciences sectors, similar to companies like Medtronic (MDT) or Danaher (DHR) where executives also receive and manage equity awards.

Stakeholder Impact

• Shareholders: Minimal direct impact as it's a routine tax-related transaction, not a discretionary sale. It reflects the ongoing compensation structure for executives.
• Employees: No direct impact.
• Customers/Suppliers/Creditors: No direct impact.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary disposition of shares by an executive for tax withholding purposes upon the vesting of restricted stock units. Such transactions are standard practice in executive compensation and do not provide new material information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Investors should maintain their current position based on broader company fundamentals and market conditions.

Keywords

Becton Dickinson, BDX, Michael Feld, Form 4, Insider Transaction, Stock Award, Tax Withholding, Executive Compensation, Life Sciences